Pulmonx Corporation (LUNG)
NASDAQ: LUNG
· Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Sep 26, 2025, 3:59 PM
1.75
0.47%
After-hours: Sep 26, 2025, 06:39 PM EDT
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 2.03M | 2.79M | 1.66M | 1.28M | 802K | 698K | 821K | 814K | 792K | 596K | 786K | 637K | 724K | 719K | 872K | 756K | 875K | 911K | 841K | 827K |
| Asia Pacific Revenue Growth | -27.48% | +68.17% | +30.15% | +59.23% | +14.90% | -14.98% | +0.86% | +2.78% | +32.89% | -24.17% | +23.39% | -12.02% | +0.70% | -17.55% | +15.34% | -13.60% | -3.95% | +8.32% | +1.69% | n/a |
| Emea Revenue | 7M | 5.48M | 6.12M | 5.13M | 5.96M | 5.12M | 4.64M | 4.85M | 5.31M | 4.53M | 5.13M | 4.41M | 4.57M | 4.05M | 5.48M | 5.61M | 4.75M | 4.04M | 4.11M | 4.44M |
| Emea Revenue Growth | +27.63% | -10.44% | +19.38% | -13.96% | +16.52% | +10.23% | -4.35% | -8.66% | +17.24% | -11.61% | +16.37% | -3.61% | +12.76% | -26.07% | -2.25% | +18.09% | +17.43% | -1.49% | -7.55% | n/a |
| Other International Geographical Areas Revenue | 102K | 38K | 101K | 145K | 139K | 171K | 96K | 164K | 68K | 71K | 57K | 58K | 40K | 6.01M | 79K | 37K | 12K | n/a | 10K | n/a |
| Other International Geographical Areas Revenue Growth | +168.42% | -62.38% | -30.34% | +4.32% | -18.71% | +78.12% | -41.46% | +141.18% | -4.23% | +24.56% | -1.72% | +45.00% | -99.33% | +7511.39% | +113.51% | +208.33% | n/a | -100.00% | n/a | n/a |
| United States Revenue | 14.73M | 14.22M | 15.88M | 13.84M | 13.88M | 12.87M | 13.72M | 11.84M | 11.02M | 9.34M | 9.46M | 8.4M | 8.62M | n/a | 7.28M | 6.86M | 6.57M | 4.29M | 4.87M | 5.34M |
| United States Revenue Growth | +3.59% | -10.44% | +14.77% | -0.32% | +7.86% | -6.20% | +15.90% | +7.40% | +18.05% | -1.26% | +12.54% | -2.48% | n/a | n/a | +6.05% | +4.46% | +53.11% | -12.00% | -8.81% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 26.7M | 26.15M | 27.11M | 25.41M | 25.31M | 24.3M | 24.32M | 23.98M | 23.46M | 22.74M | 21.91M | 19.72M | 21.23M | 20.25M | 18.91M | 16.69M | 17.62M | 15.6M | 13.96M | 10.81M | 11.11M | 10.19M | 10.02M | 8.62M | 8.36M | 7.78M |
| Selling, General, and Administrative Revenue Growth | +2.11% | -3.53% | +6.67% | +0.38% | +4.16% | -0.08% | +1.41% | +2.22% | +3.20% | +3.78% | +11.11% | -7.15% | +4.89% | +7.07% | +13.32% | -5.30% | +12.92% | +11.78% | +29.10% | -2.69% | +9.06% | +1.65% | +16.27% | +3.16% | +7.43% | n/a |
| Research and Development Revenue | 5.31M | 4.76M | 5.72M | 3.74M | 3.9M | 4.21M | 3.9M | 4.22M | 5.71M | 4.25M | 3.9M | 4.37M | 3.59M | 3.53M | 3.71M | 2.81M | 3.51M | 3.03M | 2.47M | 2M | 1.43M | 1.56M | 1.6M | 1.4M | 1.45M | 1.52M |
| Research and Development Revenue Growth | +11.56% | -16.82% | +52.72% | -3.95% | -7.41% | +8.06% | -7.68% | -26.09% | +34.26% | +8.97% | -10.60% | +21.48% | +1.70% | -4.69% | +31.72% | -19.71% | +15.56% | +22.73% | +23.79% | +40.04% | -8.88% | -2.37% | +14.58% | -3.65% | -4.69% | n/a |